Xeomin® (incobotulinumtoxinA) Data To Be Presented At The 71st Annual Assembly Of The American Academy Of Physical Medicine And Rehabilitation

Merz Pharmaceuticals announced that data from stability and clinical studies evaluating Xeomin® (incobotulinumtoxinA), a botulinum toxin type A free from accessory proteins, will be presented at the 71st Annual Assembly of the American Academy of Physical Medicine and Rehabilitation (AAPM&R) in Seattle, Wash. The U.S…

How e-Health Can Improve Men’s Health, Australia

Currently five men die every hour in Australia from potentially preventable illnesses, which are not detected early enough, yet despite this staggering number, men are still reluctant to go and see a GP…

Medtronic Marks Bladder Health Awareness Month With National Women’s Health Campaign

In support of Bladder Health Awareness Month and the struggles 33 million Americans face year-round with bladder control issues, Medtronic, Inc. (NYSE: MDT) is extending its national women’s health campaign, Facing Our Moments Together™…